k 0 $0397 JUN 9 = 2005
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
SYNERON MEDICAL Ltd. VELASMOOTH, SHAPER

This summary of safety and effectiveness information is being submitted in

accordance with the rcquircments of the SMDA 1990 and 21 CFR 807.92.

Submitter: Syneron Medical Ltd., Sultam Industrial park, P.0.R.550,
Y okneam Elite 20692, Israel.

Tel. +972-4-909-6200 ext. 352, Fax +972-4-909-6202

Name of the Device: Vela smooth, Shaper

Predicate Devices: Vela smooth, Shaper is substantially equivalent to a
combination of the following devices: LPG therapeutic
massager, manufactured by LPG systems and subject of
K990445. WS-501 Heat lamp, manufactured by Lhasa Medical
Inc. and subject of K0I3197. TDP CQ-27 heat lamp,
manufactured by Lhasa Medical, Inc. and subject of K003538.
Aurora DS, manufactured by Syneron medical Ltd. and subject
of K031988. ThermaCool TC, manufactured by Thermage Inc.
and subject of K030142.

Device Description; The Vela smooth, Shaper treatment is based on the

simultaneous application of heat to the tissue with light energy
at a controlled Infrared wavelength, conducted RF energy, and
mechanical manipulations of the skin.
The Vela smooth, Shaper is indicated for the relief of minor
muscle aches and pain. Relieve of muscle spasm. Temporary
improvement of local blood circulation. Temporary reduction
in the appearance of cellulite.

Based upon an analysis of the overall performance characteristic for the device,

Syneron Medical Ltd. believes that no significant differences exit. Therefore the Vela

smooth, Shapershould raise no new issues of safety or effectiveness.

February 13, 2005 | . ‘ War

Date r. Amir Waldman,

Director regulatory affairs
Syneron medical Ltd.

ey : ;
ri ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
% eee
JUN 9 = 2008 osb0Comporamboulsard
Rockville MD 20850
Syneron Medical, LTD.
C/o Mr. Donald E. Segal
Alston & Bird, LLP ,
601 Pennsylvania Avenue, N.W. .
North Building, 10" floor
Washington, District of Columbia 20004
Re: K050397
Trade/Device Name: Vela smooth, Shaper
Regulation Number: 21 CFR 878.4810 °
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology
Regulatory Class: II
Product Code: NUV
Dated: May 23,2005
Received: May 23,2005
Dear Mr. Segal:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for iinnual registration, listing of
devices, good manufacturing practice, labeling, and prohibitionsagainst misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA),
it may be subject to such additional controls. Existing major regulations affecting your device
can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA
may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalencedetermination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulationsadministered by other Federal agencies. Y ou must
comply with all the Act's requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Donald E. Segal *
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarketnotification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your
device to proceed to the market.
If you desire specific advice for your device on our labeling regulation(21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the A ct from the Division of Small
Manufacturers, International and Consumer <A ssistanceat its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http:/Avww.fda.gov/cdrh/industry/support/index.html.
: (07 Uf A _~
+ ake C. Provost, Ph.D.
Acting Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure
I |

Indications for Use
§10(k) Number (if known) ; K050397
Device Name: Vela smooth, Shaper.
Indications For Use: The Vela smooth, Shaper is indicated for the relief
Of minor muscle aches and pain. Relief of muscle spam
Temporary improvement Of local blood circulstion.
Temporary reduction in the appearance of celinite.
PrescriptionUse__ x AND/OR Over-The-CounterUse
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
iT
_-kKFvision Sign-Oil)
Gissien Cones, “er*arative
ad Neurological Devices Page lof_1
‘DDS vow yer KOO S77 J Z .

